Novotech reaches deal to bring early phase trials to Bangkok hospital

AccorHotels Group has partnered with Thailand-based developer Khaolak Inter to open a new Pullman hotel in Khao Lak, Thailand.
Novotech to collaborate with Bangkok’s Phramongkutklao hospital and clinical research center on early phase clinical trials. (AccorHotels Group)

Australian-based CRO Novotech has entered into a collaboration with Bangkok’s Phramongkutklao hospital and clinical research center to conduct early phase clinical trials.

Under the agreement, Novotech will partner with the hospital and will conduct early phase studies at its research center while it provides feasibility assessments and recruit patients for studies.

Dr. Yooni Kim, Novotech’s executive director of Asian operations, cited Bangkok’s rapid growth and increasing focus on advanced medical care and supporting facilities.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The collaboration “means Novotech will have dedicated clinical experts within the hospital to support and prioritize rapid clinical processes” for its biopharma clients, Kim said in a statement.

Novotech has said increasing use of Asia and Asia-Pacific regions as sites for clinical trials supports the need for partnerships with CROs that understand and can leverage market nuances.

In July, Novotech inked a partnership with Philippines-based ophthalmology firm Asian Eye Institute for clinical research.

Financial details of that deal and the agreement with Phramongkutklao weren’t disclosed.